Antihypertensive effect and vascular regulation mechanism of rhynchophylline on spontaneously hypertensive rats

Chinese Traditional and Herbal Drugs

Volumn 45, Issue 15, 2014, Pages 2210-2213

  Tian, Li Na ^a   Gao, Hua Wu ^a   Long, Zi Jiang ^a   Tang, Li Qin ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Ang II; Asymmetric dimethylarginine; Nitric oxide synthase; Rhynchophylline; Spontaneously hypertensive rats

Indexed keywords

CAPTOPRIL; RHYNCHOPHYLLINE; WATER;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD SAMPLING; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

EID: 84921502178     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: 10.7501/j.issn.0253-2670.2014.15.017     Document Type: Article

References (4)

1. Vasilev V, Matrozova J, Elenkova A, et al. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1 (sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma[J]. Exp Clin Endocrinol Diabetes, 2013, 121: 551-555.
2. Martin S, Priit K, Jaak K, et al. Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension[J]. Blood Press, 2011, 20: 111-116.
3. Veresh Z, Debreczeni B, Hamar J, et al. Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-angiotensin system and reactive oxygen species[J]. J Vasc Res, 2012, 49: 363-372.
4. Ando R, Ueda S, Yamagishi S, et al. Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction[J]. Diabet Vasc Dis Res, 2013, 10(5): 436-441.